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Lipid membraneTranslocator protein TSPO is a membrane protein highly conserved in evolution which does not belong to any
structural known family. TSPO is involved in physiological functions among which transport of molecules such
as cholesterol to form steroids and bile salts in mammalian cells. Membrane protein structure determination re-
mains a difﬁcult task and needs concomitant approaches (for instance X-ray- or Electron-crystallography and
NMR). Electron microscopy and two-dimensional crystallization under functionalized monolayers have been
successfully developed for recombinant tagged proteins. The difﬁculty comes from the detergent carried by
membrane proteins that disrupt the lipid monolayer.
We identiﬁed the best conditions for injecting the histidine tagged recombinant TSPO in detergent in the
subphase and to keep the protein stable. Reconstituted recombinant protein into a lipid bilayer favors its adsorp-
tion to functionalized monolayers and limits the disruption of the monolayer by reducing the amount of deter-
gent. Finally, we obtained the ﬁrst transmission electron microscopy images of recombinant mouse TSPO
negatively stained bound to the lipid monolayer after injection into the subphase of pre-reconstituted TSPO in
lipids. Image analysis reveals that circular objects could correspond to an association of at least four monomers
of mouse TSPO.
The different amino acid compositions and the location of the polyhistidine tag between bacterial and mouse
TSPO could account for the formation of dimer versus tetramer, respectively. The difference in the loop between
the ﬁrst and second putative transmembrane domain may contribute to distinct monomer interaction, this is
supported by differences in ligand binding parameters and biological functions of both proteins.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Translocator protein (18 kDa, TSPO), previously known as the
peripheral-type benzodiazepine receptor [1] is a transmembrane
protein that is evolutionarily conserved from bacteria to humans
[2,3]. TSPO is expressed in almost all mammalian tissues and is most-
ly located in the outer mitochondrial membrane [3]. TSPO is involvedhenyl)-N-methylisoquinoline-
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rights reserved.in a wide range of physiological functions and the best established
molecular one is the translocation of cholesterol from the cytosol to
themitochondrialmatrix, theﬁrst step of steroids or bile salts formation
in steroidogenic tissues and liver, respectively [4]. However, little is
known about its three-dimensional atomic structure, oligomeric state,
and its molecular mechanism. Initial hydropathy analysis suggested
ﬁve transmembraneous domains for TSPO that were conﬁrmed by
topological studies [5]. Further, biophysical studies of peptides en-
compassing putative transmembrane domains and recombinant
mouse TSPO demonstrated the ﬁve-helix fold of TSPO [6]. More recent-
ly, the ﬁrst three-dimensional structure of TSPO from R. sphaeroideswas
obtained by electron cryomicroscopy of helical crystals [7]. From a func-
tional point of view, theminimal unit for mammalian TSPO seems to be
a monomer since recombinant mouse TSPO binds high afﬁnity drug li-
gand PK 11195 and cholesterol [8]. However, several data suggest that
TSPO is associated with other proteins either from the cytosol or from
the mitochondrial membranes in the steroid biosynthesis for instance
[9,10]. Moreover, it has been suggested that, in response to reactive
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tional properties [11]. Another possibility is the transient association of
TSPO to form non‐covalent polymers and this would be an explanation
for the dimers observed in the tubular crystals of TSPO frombacteria [7].
Nevertheless, differences between species cannot be excluded. Thus,
characterization of structural differences betweenmammalian and bac-
teria TSPO is an important issue.
Structural studies of membrane protein are intricate and several
approaches are possible [12]. Among them, electron microscopy can
be used to study membrane protein organization within the artiﬁcial
membranes either by two-dimensional crystallization in solution or
by reorganization of adsorbed proteins under a lipid monolayer at
the air/water interface [13–15]. The latter has the advantage of con-
centrating tagged recombinant proteins under functionalized mono-
layers and in some case, allows to analyze isolated particles. The
main difﬁculty to solve is the solubilizing effect of the detergent asso-
ciated to the protein. Indeed, the detergent is necessary to stabilize
the recombinant membrane protein, but it also solubilizes the lipid
monolayer which is actually the matrix on which the protein in solu-
tion will interact. In this paper, we present a new strategy to over-
come this problem by injecting pre-reconstituted membrane protein
in lipid bilayer under the functionalized lipid monolayer. In this
study, we show for the ﬁrst time an image of a mammalian TSPO
which suggests a different oligomeric state compared to bacterial
orthologue described in a previous work using image analysis from
an electron micrograph. Mammalian and bacterial TSPO have differ-
ent number and composition of amino acids, their recombinant
forms have a polyhistidine tag located in the C-terminus versus
N-terminus, respectively. These differences may account for different
polymeric associations. The loop between the ﬁrst and the second pu-
tative transmembrane domains may be crucial in protein–protein as-
sociation since it has been proposed to participate in bacterial TSPO
dimer formation. In addition distinct ligand binding and transported
molecules have been reported between mammalian and bacterial
TSPO, giving different biological functions for these two proteins.2. Material and methods
Lipids, detergent and protein: all lipids used in this studywere pur-
chased from Avanti Polar Lipids. Monolayer lipid ligand and diluting
lipid are 1,2-dioleoyl-sn-glycero-3-[(N-(5-amino-1-carboxypentanyl)
iminodiacetic acid)succinyl] (Nickel salt) later named DOGS-NTA-Ni,
and 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC). These lipids
were prepared in an organic solvent mixture chloroform/methanol
(v/v) and stored at −20 °C. Lipids used for proteoliposomes were
1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) and 1,2-
dimyristoyl-sn-glycero-3-phosphoethanolamine (DMPE) mixed
in organic solvent at a DMPC/DMPE ratio of 9/1 (w/w), then solvent
was removed and lipids resuspended in water and stored at−20 °C.
Detergent: sodium dodecylsulfate (SDS) was purchased from
Sigma-Aldrich (France).
TSPO protein: His-tagged mouse recombinant TSPO was over-
expressed in E. coli bacteria and puriﬁed in SDS as described [16,17].
TSPO reconstitution: DMPC/DMPE lipid mixture was added to
mouse recombinant TSPO puriﬁed in SDS to full solubility and SDS
was removed by incubation with Bio-beads SM2 (BioRad, France) as
described [8,18].
SDS removal was followed using a homemade protocol previously
described [18].
TSPO intrinsic ﬂuorescencewas performed using a PTI spectrophotom-
eter (Serlabo Technology, France) equipped with a stirrer and a
temperature-controlled cell. Excitation and emission wavelengths were
set at 290 and 340 nm, respectively. The slits were set at 2 and 4 nm for
excitation and emission, respectively. Experiments were performed at
room temperature, 20 °C.TSPO high afﬁnity ligand bindingwasmeasured using proteoliposomes
and radioactive [3H] PK 11195 as described [18]. The Kd value for PK
11195 was determined by curve ﬁtting using the following equation:
PK 11195 bound to TSPO protein %ð Þ
¼ 100  PK 11195½ = Kdþ PK 11195½ ð Þ
In our data, 100% of binding was measured to be equal to 25±
2 nmol PK 11195 bound per milligram of TSPO.
Monolayers: monolayers were prepared in a 8 mL Teﬂon trough
(S=20 cm2) ﬁlled with buffer (50 mM, Tris–HCl at pH 8). Surface
pressure was measured using the Wilhelmy method (Nima Technol-
ogy, Coventry, UK).
Ellipsometry measurements were carried out with an in-house au-
tomated ellipsometer [19,20] in a “null ellipsometer” conﬁguration
[21]. He–Ne laser beam (λ=632.8 nm, Melles Griot) was polarized
with a Glan–Thompson polarizer and reﬂected on the surface of the
trough (incidence angle of 52.12°). After reﬂection on the liquid sur-
face, the laser light passed through a λ/4 retardation plate, a Glan–
Thompson analyzer and a photomultiplier. The analyzer angle, multi-
plied by two, yielded the value of the ellipsometric angle (Δ) i.e., the
phase difference between parallel and perpendicular polarization of
the reﬂected light. The laser beam probed a surface of 1 mm2 and a
depth in the order of 1 μm. Initial values of the ellipsometric angle
(Δ0) and surface tension of pure buffer solutions were recorded on
the subphase for at least half an hour. These values have been
subtracted from all data presented below. Values of Δ were stable
and recorded every 4 s with a precision of ±0.5°.
Brewster Angle Microscopy (BAM) [22] observations were carried out
with a device mounted on the ellipsometer apparatus, allowing the
visualization of the surface during protein adsorption. The interface is il-
luminated at the air–water Brewster incidence (53.1°) with He\Ne laser
(λ=632.8 nm, Melles-Griot, France) and the reﬂected beam is cap-
tured by a CCD video camera giving an image of the monolayer. The
contrast is due to a change in the reﬂexion coefﬁcient of the polarized
incident light on the surface due to a change in the refractive index of
the interface upon adsorption of molecules. If the molecules are not
adsorbed at the interface, the grey level is equal to the background
level and the picture is dark. On contrary, when the molecules are
adsorbed at the interface, the induced modiﬁcation of the refractive
index changes the reﬂexion coefﬁcient of the incident polarized light
and the gray level is higher than the background level in all places
where molecules are present. Hence, domains appear as bright regions
on a dark backgroundwhile a homogeneous layer appears as a homoge-
neous bright picture. Our device does not allow to quantify the exact
amount of molecules present at the interface but the comparison be-
tween gray levels gives an indication on the relative amount of mole-
cules. The resolution of the system is a few μm.
Transmission Electron Microscopy (TEM): solution samples were
deposited on carbon-coated grids (400 mesh, EMS); monolayers
were picked up by placing a carbon-coated grid either on the surface
of the monolayer through or on top of the well for several minutes. In
all cases, grids were blotted with ﬁlter paper and negatively stained
with 2% (w/w) uranyl acetate for 30 s. Images were recorded with a
JEOL 1200EX operated at 80 kV or a FEI Philips CM120 operating at
100 kV.
Image analysis: selected electron micrographs were digitized with
a Nikon ﬁlm scanner (Super cool scan 9000 ED) at 2000 pixels/in.
Digitized images were ﬁrst treated to increase contrast and to per-
form object picking using IMOD program [23]. Then, subimages
were aligned rotationally and translationally generating an averaged
image. Brieﬂy, all images were compared by cross correlation, rotated
and translated to get the best match using classical protocol available
in SPIDER program [24].
Finally, correspondence analysiswas followed byhierarchical ascen-
dant classiﬁcation using SPIDER program [25] leading to homogeneous
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work classiﬁcation using the Xmipp program [26].
3. Results and discussion
3.1. Monolayer stability
An amount of 6 nmol of DOGS-NTA-Ni/DOPC 1/6 mol/mol in or-
ganic solvent (chloroform/methanol 1/1 v/v) was spread at the in-
terface air/Tris–HCl (50 mM, pH=8) at an initial surface pressure
of 26 mN/m. This value of surface pressure ensures that the mono-
layer maintains its ﬂuidity allowing the subsequent reorganization
of the complex lipid protein at the interface after protein injection [27].
The corresponding value of the ellipsometric angle is around 6.5°, as
shown in Fig. 1A and B before SDS injection, which is typical for lipid
monolayers with this composition [28]. As puriﬁed recombinant TSPO
(at 15×10−3 g/L) is associated with SDS at 45×10−3 g/L, the stability
of the lipid monolayer is tested in the presence of pure SDS, for two SDS
subphase concentrations (60×10−3 g/L and 160×10−3 g/L) well
below the micellar concentration which is 1000×10−3 g/L.
Fig. 1A shows that the injection of SDS, at a subphase concentration
of 60×10−3 g/L induces a biphasic kinetics: a fast increase of the sur-
face pressure of up to 40 mN/m, followed by a slow continuous de-
crease of ca. 4 mN/m over 6 h after SDS injection. The ellipsometric
angle follows a similar transient increase followed by an overall
decrease of 1.5° over 6 h after SDS injection, reaching ﬁnally the value
of 5°. An injection of SDS at a concentration three times higher
(160×10−3 g/L) but still lower than themicellar concentration induces
the same effects, with however, somewhat faster kinetics (Fig. 1B). A
fast increase of the surface pressure up to 41 mN/m is followed by a
slow decrease of roughly 6 mN/m over 6 h after injection, correlated
in the same time with a decrease of the ellipsometric angle of 2.5° lead-
ing to a ﬁnal value of 4° after 7 h.
Both effects result from the initial insertion of SDS in the lipidmono-
layer, inducing a fast increase in the surface pressure. Then, SDS pro-
gressively replaces the lipids resulting in the decrease of the
ellipsometric angle since the SDSmolecule is smaller than the lipidmol-
ecule as reﬂected by the difference of the ellipsometric angle for a pure
lipid monolayer (6.5°) compared to a pure SDS monolayer (1.8°) as
shown by the dashed line on Fig. 1A and B.
These results provide information on lipidmonolayer stability in the
presence of SDS: a perturbing effect of SDS on DOGS-NTA-Ni/DOPC can-
not be excluded (even at the lowest SDS concentrations) resulting in
the progressive removal of lipid from the interface to the subphase.
However, these results also show that a high amount of ligand
lipid remains at the interface for 6 h after SDS injection. Indeed, theA B
Fig. 1. Effect of SDS on DOGS-NTA-Ni/DOPC monolayer. Surface pressure (dark circles) and e
SDS is injected in the subphase beneath the lipid monolayer. A) Final SDS concentration of
(injection in arrow 2). In both graphs, dashed line corresponds to the ellipsometric angle oellipsometric value of this layer (around 5-6°) remains closer to the
value expected for a pure lipid than for a pure SDS monolayer (6.5°
and 1.8°, respectively). Hence, it can be considered that the removal
of lipids from the interface towards to the subphase, due to SDS, is a
phenomenon which takes place in a period of several hours and has
little impact on the lipid monolayer stability on the ﬁrst hour.
Hence, if TSPO is injected during the ﬁrst hour after the lipid mono-
layer spreading, it will interact with a dense lipid monolayer.3.2. Comparison between injection of TSPO/SDS and of TSPO/SDS/lipids
23 μL of the binary mixture—histidine tag recombinant TSPO
(5.23 g/L) puriﬁed in SDS (15.7 g/L)—was injected in the buffer
subphase (8 mL), below the functionalized monolayer DOGS-NTA-Ni/
DOPC prepared under the same conditions as described above, with
an initial surface pressure of 25 mN/m and an ellipsometric angle of ap-
proximately 6.5°. The dilution factor is then 348.8 and the ﬁnal concen-
trations of TSPO and SDS are respectively, equal to 15×10−3 g/L and
45×10−3 g/L. As in the case of pure SDS injection, a fast increase of
the surface pressure of up to 36 mN/m is observed, followed after ca.
4 h by stabilization around 32 mN/m (Fig. 2A). The corresponding
ellipsometric kinetics shows a scattered behavior around 6° during
the ﬁrst hour, corresponding to the sharp increase of the surface pres-
sure, followed by stabilization around 6° over 7 h after injection.
The Brewster Angle Microscopy (BAM) observation of the interface
at 13 h after injection, (shown in Fig. 2B; See Material and methods
for the interpretation of BAM pictures) reveals the heterogeneity of
the surface at the micrometric scale. This interfacial layer was subse-
quently transferred to electron microscopy grids. The observations of
the grids with Transmission ElectronMicroscopy (TEM) show the pres-
ence of TSPO on the grids and therefore highlights the adsorption of
TSPO to the monolayer (Fig. 2C).
Hence, the high increase in surface pressure from 25 mN/M to
32 mN/m and the constant value around the initial value of 6° of the
ellipsometric angle suggest that TSPO is inserted in the lipidmonolayer,
which is not a favorable conﬁguration to obtain organized structures at
the interface.
A control experiment, where the monolayer is made only of DOPC
(no DOGS-NTA-Ni present) and the TSPO is injected as described
above does not show any heterogeneity on BAM pictures (data not
shown). In this control case, the kinetics is similar to that previously
observed in Fig. 1A when pure SDS is injected: a fast increase of sur-
face pressure and of ellipsometric angle, followed by a slow decrease
of these two parameters. These results suggest that TSPO does not ad-
sorb to the monolayer in the absence of ligand lipid and that the purellipsometric angle (open square) of DOGS‐NTA-Ni/DOPC monolayer are recorded while
60×10−3 g/L (injection in arrow 1) and B) ﬁnal SDS concentration of 160×10−3 g/L
f the pure SDS saturated monolayer.
50 µm
50 µm
A
C
B
F
E
D
1
2
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Fig. 2. Adsorption of TSPO injected beneath DOGS-NTA-Ni/DOPC monolayer alone or in presence of lipids. A) Surface pressure (dark circles) and ellipsometric angle (open square)
are recorded when a binary mixture of ﬁnal concentration TSPO (15×10−3 g/L) and 45×10−3 g/L SDS (injection in arrow 1) is injected in the subphase below the DOGS-NTA-Ni/
DOPC monolayer. B) BAM picture taken 13 h after binary mixture injection, showing bright domains attributed to protein adsorption. C) TEM picture taken 13 h after binary mix-
ture injection (TSPO, SDS), showing stained patches corresponding to adsorbed TSPO “aggregates” (white arrow). D) Surface pressure and ellipsometric angle are recorded when a
ternary mixture of a ﬁnal concentration TSPO (15×10−3 g/L), lipids (10.5×10−3 g/L DMPC/DMPE) and SDS (160×10−3 g/L) (injection in arrow 2) is injected in the subphase
below DOGS-NTA-Ni/DOPC monolayer. E) BAM picture taken 17 h after injection of the ternary melt (TSPO, lipids and SDS), the bright homogeneous image indicates that the
amount of adsorbed molecules is higher than in the previous (binary mixtures F,G) TEM pictures taken 17 h after injection, showing worm like stained patches (F, white arrow)
and sheets surrounded by a dense material corresponding to proteolipidic objects. On both graphs (A and D), the dotted line shows the ellipsometric angle of a SDS monolayer
formed from a solution at 2 g/L.
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same behavior towards SDS.
In order to increase the amount of protein adsorbed to themonolay-
er, a possibility is to inject a mixture of TSPO/SDS and lipids, since the
best environment for membrane proteins is lipids. Hence, 120 μL of
the ternary mixture TSPO (1 g/L), SDS (10 g/L) and lipids (0.7 g/L
DMPC/DMPE) was injected in the buffer subphase (8 mL), below the
functionalized monolayer DOGS-NTA-Ni/DOPC prepared under the
same conditions as described above with an initial surface pressure of
25 mN/m and an ellipsometric angle of approximately 6.5°. The dilution
factor is then 67.7 and the ﬁnal concentration for each constituent of the
ternary mixture is: TSPO (15×10−3 g/L), SDS (160×10−3 g/L) and
lipids (10.5×10−3 g/L DMPC/DMPE).
In that case, the surface pressure shows a smaller initial increase
than previously, reaching a value of 30 mN/m that remains stable
over all the kinetics. During the same time, the ellipsometric angle is
highly scattered, it decreases from 6.5° to an average value of 4.5° dur-
ing the initial ﬁrst 2 h after the injection, probably due to the removal of
lipid from the interface by SDS, and subsequently shows an increase of
2.5° (i.e. up to 7°) following 6 h (Fig. 2D). Themoderate increase of sur-
face pressure from 25 mN/m to 30 mN/m and the higher relativeincrease of the ellipsometric angle from 4.5° to 7° suggest that TSPO
molecules injected in a ternary mixture TSPO/SDS/(DMPC/DMPE) are
adsorbed beneath the lipid monolayer in a higher amount compared
to TSPO injected in a binary mixture TSPO/SDS. This is conﬁrmed by
the homogeneous and brighter BAM picture compared to Fig. 2B,
taken 17 h after injection (Fig. 2E; SeeMaterial and methods for the in-
terpretation of BAM pictures). Furthermore, TEM images reveal the
presence of small proteolipidic objects (Fig. 2F and G). However, these
objects were not organized at the interface. The smaller increase of sur-
face pressure also shows that, although the ﬁnal SDS concentration in
the ternary mixture is higher (160×10−3 g/L against 45×10−3 g/L)
than in previous experiments with identical TSPO concentration
(15×10−3 g/L), the presence of DMPC/DMPE lipids reduces the impact
of SDS on lipid monolayer. Indeed, the increase of surface pressure is
smaller, probably due to a smaller insertion of SDS in the lipidmonolay-
er. This suggests that SDS interacting also with the DMPC/DMPE lipids
reduces the free SDS in the subphase.
These results show that the presence of lipids (DMPC/DMPE)
with the TSPO protein in the injection promotes the adsorption
of TSPO as proteolipidic objects at a functionalized monolayer
(DOGS-NTA-Ni/DOPC). Thus, TSPO tends to remain in solution when
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located at the functionalized monolayer when associated with lipids
and SDS in ternary complexes. This could be explained by the com-
bined effects of DMPC/DMPE and TSPO that, by reducing the concen-
tration of free SDS, inﬂuence the action of SDS on the lipid monolayer.
We hypothesize that SDS could hinder the interaction between lipid
ligand and TSPO either by masking the NTA-Ni of lipid or the histidine
tag of TSPO, whereas the presence of DMPC/DMPE lipids could favor
this interaction by reducing the free SDS interaction.
We never observed large bilayers under the monolayer, suggesting
that the fusion between several proteolipidic objects does not occur and
might be prevented by the presence of too much of SDS. The lower con-
centration of SDS could promote the fusion process or the adsorption of
larger preformed objects. We suggest that this could be achieved by con-
trolling the SDS concentration in the TSPO-DMPC/DMPE lipids mixture
before the injection.B
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Fig. 3. (A) Time course of SDS removal by Bio-bead addition. At time zero, 100 mg
(open symbols) or 145 mg (closed symbols) of Bio-beads was added to a mixture
of TSPO (0.1 mg/mL), lipids (0.1 mg/mL (open triangles and closed circles) or
0.5 mg/mL (open squares) DMPC/DMPE, 9/1) and SDS (1.2 mg/mL). A second addition
of 100 mg of Bio-beads was performed (arrow) 75 min after the ﬁrst addition to
completely remove SDS from the mixture of TSPO and lipids (open squares).
(B) Time course of intrinsic ﬂuorescence changes. A sample of the different mixtures
of TSPO, lipids and SDS (same symbols as in panel A) was taken at different times of in-
cubation with Bio-beads and ﬂuorescence measured with excitation and emission
wavelengths set at 290 nm and 340 nm, respectively. Data were plotted as a ratio of
ﬂuorescence changes upon initial ﬂuorescence. (C) PK 11195 ligand binding saturation
curve. Proteoliposomes of mouse TSPO reconstituted in DMPC/PE at a lipid over protein
ratio of 5 (w/w) were incubated in the presence of increasing concentration of radioac-
tive PK 11195, ﬁltered and radioactivity retained in the ﬁlter measured. Non‐speciﬁc
binding measured with an excess of non‐radioactive PK 111195 was subtracted. Afﬁn-
ity constant (Kd=6±3 nM) was estimated by ﬁtting the curve with saturation curve
described in Material and methods.3.3. Use of pre-reconstituted proteolipidic objects
It has been previously described that detergent removal from a
mixture of protein, lipids and detergent leads to the formation of
proteoliposomes with different intermediate states including sheets
and batonnets [29–31]. Controlling how the detergent is removed
from the solution allows to obtain a proteolipidic object of a different
size [32]. This controlled removal can be achieved using hydrophobic
Bio-beads™ that adsorb detergents [33].
Fig. 3A shows that SDS removal from a mixture of TSPO, lipids
(DMPC/PE) and SDS can be controlled by the amount of Bio-beads
added in the medium. At a Bio-beads to SDS ratio of 17 w/w
(corresponding to 100 mg added to 5 mL solution containing
1.2 mg/mL SDS), 75% of the detergent is removed in less than 1 h. Com-
plete detergent removal can be achieved either by increasing the initial
amount of Bio-beads added (circles in Fig. 3A, ﬁnal Bio-beads to SDS
ratio of 24), or by a second addition (100 mg at the arrow in Fig. 3A,
ﬁnal Bio-beads to SDS ratio of 33). Detergent removal around TSPO and
its substitution by lipids induces a large change in intrinsic ﬂuorescence
of the protein (Fig. 3B). This process ismuch slower than thedetergent re-
moval suggesting a structural reorganization of the protein. Previous data
using circular dichroism showed that the secondary structure of TSPO
was slightly different in the presence of various detergents surrounding
the protein [34]. This transition seems important for the functionality of
TSPO since TSPO reincorporation in liposomes enables the measurement
of high afﬁnity drug ligand binding, PK 111195 (Fig. 3C) as previously de-
scribed [8]. Afﬁnity constant (6±3 nM) that can be deduced by data
ﬁtting with saturation curve, is close to that measured in vivo [1,3].
We incubated the ternary monodispersed mixture of TSPO (1 g/L),
SDS (10 g/L) and lipids (0.7 g/L DMPC/DMPE) for 1 h in the presence
of two different Bio-beads to SDS ratios (3.6 w/w and 20 w/w, named
BB3.6 and BB20, respectively). Following incubation, TEM images
taken for each specimen allow to characterize the kind of reconstitution
state of TSPO in DMPC/DMPE. The initial state, before the addition of
Bio-beads is shown in Fig. 4A. No structure was observable since in
the absence of Bio-beads, the mixture contains ternary complexes of
TSPO–lipids–detergent too small to be seen. Twodifferent degrees of re-
constitution of TSPO into DMPC/DMPE were reached upon addition of
the two Bio-beads ratios: BB3.6 was giving intermediate state where
proteolipidic sheets are seen (Fig. 4B) whereas when BB20 was used,
proteoliposomes were observable (Fig. 4C).
As described in the previous paragraph, the injection of the ternary
preparations in the 8 mL buffer in the trough was expected to dilute
of a factor of 67.7 the pre-reconstituted objects. Therefore, we tested
the consequence of this dilution on these objects formed upon incuba-
tion with a Bio-beads ratio of 20 w/w.
Fig. 4D shows a MET observation of the same preparation but after
a dilution of 67.7 corresponding to the dilution induced by theinjection in the larger volume of the trough. Note that proteolipidic
objects are still present although fewer in number and with a smaller
size.
BB/SDS  20 w/w
BB/SDS  3.6 w/w
1
50 µm
Effect of dilution
After injection
Effect of dilution
A
F
C
B
D
E
H
I
G
0.1 µm
0.1 µm
0.1 µm
0.1 µm
0.1 µm
0.1 µm
0.1 µm
Fig. 4. Effect of preliminary elimination of SDS with Bio-beads on the adsorption of TSPO associated with lipids on DOGS-NTA-Ni/DOPC monolayer. A) TEM picture of the ternary
monodispersed mixture TSPO/SDS/(DMPC/DMPE) showing homogenous background with no object clearly visible, B,C) TEM pictures of the same ternary mixture as in A after re-
duction of SDS content following incubation for 1 h with different Bio-beads to SDS ratios (3.6 and 20 w/w, named BB3.6 and BB20, respectively) leading to intermediate
reconstituted state (B) characterized by grey objects in the background corresponding to sheets (arrows), and proteoliposomes (C) characterized by rounded objects with white
edge (arrows), D,F) TEM pictures showing the effect of the dilution (×67.7) occurring on the ternary mixture obtained after incubation at BB3,6 and BB20 when injected in the
trough. E) TEM picture of grids taken at the interface after injection in the trough of ternary mixture incubated at BB20 showing the presence of vesicles (arrow). G) Surface pres-
sure (dark circles) and ellipsometric angle (open square) of DOGS−NTA−Ni/DOPC monolayer recorded with time when BB3.6 solution shown in (B) is injected in the subphase
(injection in arrow 1), H) BAM picture taken 18 h after injection. The bright homogeneous picture indicates that adsorbed molecules are present at the interface and I) TEM picture
of grids taken at the interface after18 h following the injection of ternary mixture incubated at BB3.6. Patches (arrow) are more dense and larger than those observed in the initial
solution injected (B) and many more are present compared to those observed upon dilution (4F).
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below theDOGS-NTA-Ni/DOPCmonolayer inducesminormodiﬁcations
of the surface pressure (except for an initial increase which is relaxed
after 2 h) and induces an increase of the ellipsometric angle of 1.5°, re-
vealing theﬁxation ofmolecules from the subphase at the interface (the
data are not shown since the kinetics has the same shape that the one
shown below on Fig. 4G).
TEM observations from the interface transferred to grids after 20 h
of incubation (Fig. 4E) show vesicles resembling to those seen in
Fig. 4C. Accordingly, the proteoliposomes are spread at the interface
after injection, but these conditions do not favor the redistribution of
TSPO on the lipid monolayer.
At this stage, we show that the injection of reconstituted complex
with a Bio-beads ratio of 20w/w does not lead to organized TSPO struc-
tures at the lipid interface. Then we decreased the Bio-beads ratio and
we incubated the TSPO ternary mixture during 1 h with BB3.6 giving
an intermediate reconstituted state.
Then, 120 μL of this preparationwas injected into the 8 mL subphase
buffer, below the functionalized monolayer DOGS-NTA-Ni/DOPC
prepared under the same conditions as described above with an initial
surface pressure of 25 mN/mand an ellipsometric angle of approximate-
ly 6.5°. Thus, the injected solution is diluted by a factor of 67.7. The
ﬁnal concentration of TSPO and DMPC/DMPE is the same as previously(respectively 15×10−3 g/L and 10.5×10−3 g/L) while SDS concentra-
tion has been lowered by the presence of Bio-beads and dilution.
The amount of SDS is not know precisely, but can be estimated to
be close to 0.1 g/L i.e. below critical micellar concentration (this estima-
tion was obtained by an interpolation at 1 h from Fig. 3A and dilution
factor).
Fig. 4B shows the preparation, using TEM, before injection into the
trough (similar to conditions described Fig. 4A). Fig. 4F shows the
same preparation but at a dilution of 67.7 mimicking the dilution
that occurs when injected in the larger volume trough. No vesicles
were detected, suggesting that a lower ratio of Bio-beads does not re-
move as much SDS as in the case of BB20, thereby preventing the for-
mation of proteoliposomes. Indeed, large detergent removal is
needed to get the closure of vesicules containing proteins and thus
formation of proteoliposomes. The injection of the BB3.6 solution
(shown Fig. 4B) under the DOGS-NTA-Ni/DOPC monolayer (Fig. 4G
arrow 1) shows a similar kinetic to that observed for the BB20 prep-
aration after injection to the subphase. The surface pressure increases
slowly up to 30 mN/mwhile the ellipsometric angle decreases during
1 h after injection and increases subsequently up to 3.5 in the follow-
ing 10 h before stabilization. This observation supports the idea that
patches of TSPO–lipid–detergent from the subphase binds to the
monolayer at the air–water interface. BAM pictures taken 18 h after
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that the binding of these patches to the lipid monolayer is rather homo-
geneous. However, BAM pictures do not allow to identify the nature of
the adsorbed objects. TEM observations of the monolayer transferred
onto electron microscopic grids after 18 h incubation after injection
(Fig. 4I) reveal the presence of objects of the same nature as those
present in the preparation ternary mixture (TSPO/DMPC-DMPE/SDS)
before injection (Fig. 4B), i.e. patches. Furthermore, we can see that
patches of sheets form larger objects than in solution forming
patchwork-like structure. This could be explained by the fact that
the dilution reduces the detergent concentration which induces
fusion-aggregation of adsorbed patches.
These results show that the controlled removal of SDS before injec-
tion of the ternary mixture (TSPO/DMPC-DMPE/SDS) in the subphase
under a functionalized monolayer prevents the insertion of the SDS
into themonolayer. The TSPO reconstituted into lipid bilayers (interme-
diate states of proteoliposome formation) can interact with the Ni2+−A
B
C
D
F
E
2 nm
1 2
4
3
2,
5 
nm
200nm
G
Fig. 5. Images of TSPO. (A) TEM picture of intermediate state of mouse TSPO and DMPC/
contained in the black box. (B,C) Averages of two subclasses obtained after correspondence a
on the right of panel C depicts overall size of average image of mouse TSPO which has a dia
jection of a dimer (E) corresponding to the densities enclosed by the orange box shown in (D
in the middle. Scheme on the right of panel E, depicts the overall size of the dimer of bacteria
level of average image of mouse TSPO (C) with four internal density peaks indicated by numb
in the average image (F).lipid monolayer through their His-tag, then the proteins bound to the
lipids are free to reorganize at the air/lipid interface.
Similar experiments were done using Teﬂon wells of 4 mm diame-
ter and containing a very small amount of solution, about 50 μL. These
smaller wells are designed to allow easy transfer of the monolayer
onto an electron microscopic grid and allow to use only a small amount
of protein [13–15].
The same preparation as before (ternary mixture of TSPO (1 g/L),
SDS (10 g/L) and lipids (0.7 g/L DMPC/DMPE) incubated with BB3.6 as
described above was injected at the same ﬁnal TSPO concentration
TSPO (15×10−3 g/L) under a DOGS-NTA‐Ni/DOPC monolayer previ-
ously stabilized at the interface. The system was incubated overnight
with a glass cover over the wells in order to prevent the evaporation
of the liquid contained in the Teﬂon well.
A TEM picture of grids after transfer of the monolayer (Fig. 5A)
shows the binding of the TSPO complex to the lipid layer and the re-
organization of the adsorbed molecules into the interfacial layer of2nm
1nm
6nm
2,5 nm
2,5 nm
2,5 nm
2,5 nm
6 nm
1 2
34
DMPE injected under DOGS-NTA-Ni/DOPC. Insert shows enlargement of the particles
nalysis containing respectively 114 and 403 images (B and C, respectively). The scheme
meter of 6 nM. (D) Cryo TEM density map of bacterial TSPO [6] used to compute pro-
). The two monomers of the bacterial TSPO are presented as contour level with a “hole”
l TSPO represented by two circles (2.5 nm diameter) enclosed in an ellipse. (F) contour
ers (1 to 4). (G) Scheme depicting the putative location of four mouse TSPO monomers
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shows a region enriched in TSPO (dark grey area). Intermediate
reconstituted states are present in the upper right corner (worm-like
object on a black background). The brightest region (light grey), at
the edge of the picture is the carbon alone, without any bound
TSPO. Fig. 5A, inset reveals numerous circular objects with a black
dot in the center. 838 individual particles were manually picked.
These particles were aligned in rotation and translation followed by
correspondence analysis (SPIDER program, [25]) leading to 800 parti-
cles correctly aligned among the 838 selected. Homogeneous classes
were generated according to the procedure described under
Material and methods [26,27] Only two classes contained enough
particles to get reliable images and to continue the image analysis
(Fig. 5B and C). The diameter of these averaged particles is about
6 nm and is greater than the 3.5 nm previously measured for a mono-
mer of TSPO protein in reconstituted proteoliposomes using freeze
fracture [9]. However, a value of 7 nm was measured for dimers of
mouse TSPO in the same work [9]. A slightly smaller value was mea-
sured for bacterial dimers of TSPO from two dimensional tubular
crystals studied in cryo TEM [6].
As part of our comparison,we used the calculated 3D densitymap of
bacterial TSPO calculated from cryo-TEM images (emdb entry: 1698).
The latter appears as a cylinder formed of stacked disks containing
each twelve TSPO homo-dimers. Fig. 5D shows an orange box including
onedimer—windowed from an isolated disk. The selected areawas sub-
sequently projected in 2D in order to compare it with our 2D class aver-
ages. Cryo-TEM images allow observing the full transmembrane TSPO
densities whereas negatively stained TEM images usually allow the vi-
sualization of the stain corresponding to accessible parts of the proteins.10        20        30    
|         |         |    
Mouse    MPESWVPAVGLTLVPSLGGFMGAYFVRGEGLRWY
Human MAPPWVPAMGFTLAPSLGCFVGSRFVHGEGLRWY
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70        80        90       100   
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Space
Fig. 6. (A) Alignment of mouse, human and Rhodobacter sphaeroides TSPO. Bars above the seq
of the predicted topology of TSPO. Loops with thick dark black lines show the main difference
for mouse and bacterial Rhodobacter sphaeroides are located.Projecting all the densities corresponding to the cryo TEMmap enclosed
in the orange box leads to the contour-level image shown in Fig. 5E. The
dissymmetry observed between the two monomers in the dimer is
explained by the curvature of the disk (due to the cylindrical nature of
the organization of the complex) therefore, the projection on a plane
of each monomer is not identical. However, both monomers clearly
show a horseshoe-like shape lacking density in the center that are
much smaller (2.5 nm) than our averages lacking also density in the
center (6 nm). Moreover, the bacterial dimer (Fig. 5E) has an ovoid
shape (see scheme on the right of Fig. 5E) whereas our averages show
more round shapes (see scheme on the right of Fig. 5C) with no central
density. Thus, our average images ofmouse TSPO cannot be amonomer,
neither a dimer.
Isodensity contour level of average image presented in panel C of
Fig. 5 reveals the presence of four densities (numbered in Fig. 5F)
suggesting a possible tetramer for mouse TSPO. Careful analysis of this
image shows that distances between these densities (2.5 nm) are com-
patible with those observed between two monomers of bacterial TSPO
conﬁrming the possible presence of four monomers. A global scheme
mimicking a tetramer (Fig. 5G) has overall dimensions (6 nm) in agree-
mentwith the arrangement of fourmonomerswithin a circle. However,
we cannot conclude about the internal arrangement of the four mono-
mers, sincemouse TSPOmonomers appear as a single density. Obvious-
ly, negative staining does not allow to reach high resolution like
cryo-TEM, where two densities can be observed for bacterial TSPO
(Fig. 5E).
The four observed densities can be obtained by severalmonomer ar-
rangements (16 in total). Some combinations can be excluded since
mouse TSPO should interact via its his-tag with the functionalized    40        50     60        70
     |         |     |         |
ASLQKPSWHPPRWTLAPIWGTLYSAMGYGSYIVWKELGG
AGLQKPSWHPPHWVLGPVWGTLYSAMGYGSYLVWKELGG
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    110       120    130
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B
uences represent putative transmembrane domains (labeled TM1 to TM5). (B) Scheme
s in sequence between mammalian and bacterial TSPO. Position of the polyhistidine tag
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where the protein is inserted are possible because of sample prepara-
tion. Indeed, insertion of membrane protein into liposomes occurs
with both orientations and in our case we have injected TSPO in a
prereconstituted state below the monolayer. A consequence will be
that in this case only some TSPO would interact by its his-tag with the
monolayer. We cannot exclude that different types of oligomeric states
of TSPO coexist in our samples preventing the formation of large
two-dimensional crystals in agreement with recent studies showing
that the oligomeric state of a membrane protein can depend of its envi-
ronment [35]. Finally, our particles show the ﬁrst images ofmouse TSPO
and even though the tetramer is most compatible with our data, further
work is needed to fully distinguish between a tetramer or dimer of
dimers.
Bacterial andmammalian TSPOhave different amino acid sequences
(Fig. 6A). TSPO from Rhodobacter sphaeroides has only 158 residues,
whereas mouse or human TSPO has 169. The C-terminus and two
loops of bacterial TSPO are reduced compared to mammalian TSPO
(Fig. 6B). It is not clear if such differences have functional consequences
and many points can be discussed. (i) The loop connecting the ﬁrst two
transmembrane helices of bacterial TSPO has been described to partici-
pate in tetrapyrrol transport [36], butmolecularmechanism involved in
the transport remains unclear. (ii) Mammalian TSPO is also able to
transport protoporphyrin (PPIX), a tetrapyrrol [1], but PPIX is a compet-
itive inhibitor of PK 11195 binding [1,36]. (iii) It has been proposed that
PK 11195 binding involves cytosolic loops of mammalian TSPO [16] and
acts as an “activator” of cholesterol transport [1,3]. However, bacterial
TSPO seems unable to bind PK 11195, thismight be due to the reduction
of loop connecting the ﬁrst two transmembrane helices (Fig. 6).
Finally, it has been demonstrated that this loop connecting the ﬁrst
and the second transmembrane helicesmight be involved in the dimer-
ization process of bacterial TSPO [37]. Wemay hypothesize that the ad-
dition of 3 residues in this loop as well as some other in the loop
connecting the second and the third transmembrane helices might be
at the origin of the different states of oligomerization observed between
bacterial [7,37] and mammalian TSPO [11,38].
4. Conclusion
In this work, the method applied to produce intermediate re-
constituted state of TSPO in the DMPC/DMPE by lowering the detergent
concentration seems to favor adsorption of proteins to functionalized
monolayers avoiding deleterious effects of detergents on the lipid
monolayer.
In addition, single particle analysis of TSPO protein observed by TEM
reveals a circular pattern for mouse TSPO distinct to the bacterial
orthologue where dimers have an ovoid shape. Image analysis suggests
the presence of four monomers for mammalian TSPO distinct to dimer
for bacterial TSPO. Several evidences have been reported for a function-
al dimer for bacteria [7,37]whereasmonomers and polymers have been
described for functional units for mammalian species [8,11]. In vivo,
studies with Positron Emission Tomography (PET) ligands have given
signiﬁcantly different results that have analyzed as single or multiple
sites, mixed-afﬁnity binding site, allosteric effects [39] suggesting that
atomic structure determination of TSPO remains a goal to reach for
describing its structure and function.
Acknowledgements
We thank Olivier Lambert for helpful discussions.
This work was supported by grants from the French National Center
for Scientiﬁc Research (CNRS), the French National Institute for Health
and Medical Research (INSERM), the French National Agency for Re-
search (ANR BLAN-0190-01 to JJL), the French Ministry of Research
(Universités Denis Diderot-Paris7, Pierre et Marie Curie-Paris6, Victor
Segalen-Bordeaux and Rennes1).References
[1] V. Papadopoulos, M. Baraldi, T.R. Guilarte, T.B. Knudsen, J.-J. Lacapère, P.
Lindemann, M.D. Norenberg, D. Nutt, A. Weizman, M.R. Zhang, M. Gavish,
Translocator protein (18 kDa): new nomenclature for the peripheral-type benzo-
diazepine receptor based on its structure and molecular function, Trends
Pharmacol. Sci. 27 (8) (2006) 402–409.
[2] J. Fan, M.B. Rone, V. Papadopoulos, Translocator protein 2 is involved in cholesterol
redistribution during erythropoiesis, J. Biol. Chem. 284 (44) (2009) 30484–30497.
[3] M. Gavish, I. Bachman, R. Shoukrun, Y. Katz, L. Veenman, G. Weisinger, A.
Weizman, Enigma of the peripheral benzodiazepine receptor, Pharmacol. Rev.
51 (1999) 629–650.
[4] J.-J. Lacapère, V. Papadopoulos, Peripheral-type benzodiazepine receptor: struc-
ture and function of a cholesterol-binding protein in steroid and bile acid biosyn-
thesis, Steroids 68 (7–8) (2003) 569–585.
[5] E. Joseph-Liauzun, P. Delmas, D. Shire, P. Ferrara, Topological analysis of the pe-
ripheral benzodiazepine receptor in yeast mitochondrial membranes supports a
ﬁve-transmembrane structure, J. Biol. Chem. 273 (4) (1998) 2146–2152.
[6] S. Murail, J.C. Robert, Y.M. Coïc, J.M. Neumann, M.A. Ostuni, Z.X. Yao, V.
Papadopoulos, N. Jamin, J.-J. Lacapère, Secondary and tertiary structures of the
transmembrane domains of the translocator protein TSPO determined by NMR.
Stabilization of the TSPO tertiary fold upon ligand binding, Biochim. Biophys.
Acta 1778 (6) (2008) 1375–1381.
[7] V.M. Korkhov, C. Sachse, J.M. Short, C.G. Tate, Three-dimensional structure of TspO
by electron cryomicroscopy of helical crystals, Structure 18 (6) (2010) 677–687.
[8] J.-J. Lacapère, F. Delavoie, H. Li, G. Péranzi, J. Maccario, V. Papadopoulos, B. Vidic,
Structural and functional study of reconstituted peripheral benzodiazepine re-
ceptor, Biochem. Biophys. Res. Commun. 284 (2) (2001) 536–541.
[9] M.B. Rone, J. Liu, J. Blonder, X. Ye, T.D. Veenstra, J.C. Young, V. Papadopoulos,
Targeting and insertion of the cholesterol-binding translocator protein into the
outer mitochondrial membrane, Biochemistry 48 (29) (2009) 6909–6920.
[10] L. Veenman, Y. Shandalov, M. Gavish, VDAC activation by the 18 kDa translocator
protein (TSPO), implications for apoptosis, J. Bioenerg. Biomembr. 40 (3) (2008)
199–205.
[11] F. Delavoie, H. Li, M. Hardwick, J.C. Robert, C. Giatzakis, G. Péranzi, Z.X. Yao, J.
Maccario, J.-J. Lacapère, V. Papadopoulos, In vivo and in vitro peripheral-type
benzodiazepine receptor polymerization: functional signiﬁcance in drug ligand
and cholesterol binding, Biochemistry 42 (15) (2003) 4506–4519.
[12] J.-J. Lacapère, E. Pebay-Peyroula, J.M. Neumann, C. Etchebest, Determining mem-
brane protein structures: still a challenge! Trends Biochem. Sci. 32 (6) (2007)
259–270.
[13] C. Vénien-Bryan, F. Balavoine, B. Toussaint, C.Mioskowski, E.A. Hewat, B. Helme, P.M.
Vignais, Structural study of the response regulator HupR from Rhodobacter
capsulatus. Electron microscopy of two-dimensional crystals on a nickel-chelating
lipid, J. Mol. Biol. 274 (1997) 687–692.
[14] D. Levy, M. Chami, J.L. Rigaud, Two-dimensional crystallization of membrane pro-
teins: the lipid layer strategy, FEBS Lett. 504 (3) (2001) 187–193.
[15] S. Courty, L. Lebeau, L. Martel, P.F. Lenne, F. Balavoine, W. Dischert, O. Konovalov,
C. Mioskowski, J.F. Legrand, C. Vénien-Bryan, Two-dimensional crystallization of a
histidine-tagged protein on monolayers of ﬂuidity-enhanced Ni2+‐chelating
lipids, Langmuir 18 (2002) 9502–9512.
[16] H. Li, V. Papadopoulos, Peripheral-type benzodiazepine receptor function in cho-
lesterol transport. Identiﬁcation of a putative cholesterol recognition/interaction
amino acid sequence and consensus pattern, Endocrinology 139 (12) (1998)
4991–4997.
[17] J.C. Robert, J.-J. Lacapère, Bacterial overexpressed membrane proteins: an exam-
ple: the TSPO, Methods Mol. Biol. 654 (2010) 29–45.
[18] M.A. Ostuni, S. Iatmanen, D. Teboul, J.C. Robert, J.-J. Lacapère, Characterization of
membrane protein preparations: measurement of detergent content and ligand
binding after proteoliposomes reconstitution, Methods Mol. Biol. 654 (2010) 3–18.
[19] B. Berge, A. Renault, Ellipsometry study of 2D crystallization of 1-alcohol mono-
layers at the water surface, EPL 21 (1993) 773–777.
[20] C. Vénien-Bryan, P.F. Lenne, C. Zakri, A. Renault, A. Brisson, J.F. Legrand, B. Berge,
Characterization of the growth of 2D protein crystals on a lipid monolayer by
ellipsometry and rigidity measurements coupled to electron microscopy,
Biophys. J. 74 (1998) 2649–2657.
[21] R.M.A. Azzam, N.M. Bashara, in: North-Holland Pub. Co. (Ed.), Ellipsometry and
polarized light, 1977, p. 529.
[22] S. Henon, J. Meunier, Microscope at the Brewster angle, direct observation of the
ﬁrst order phase transitions in monolayers, Rev. Sci. Instrum. 62 (1991) 936–939.
[23] J.R. Kremer, D.N. Mastronarde, J.R. McIntosh, Computer visualization of
three-dimensional image data using IMOD, J. Struct. Biol. 116 (1996) 71–76.
[24] J. Frank, M. Radermacher, P. Penczek, J. Zhu, Y. Li, M. Ladjadj, A. Leith, SPIDER and
WEB: processing and visualization of images in 3D electron microscopy and relat-
ed ﬁelds, J. Struct. Biol. 116 (1996) 190–199.
[25] J. Franck, Three-dimensional electron microscopy of macromolecular assemblies:
visualization of biological molecules in their native state, In: Second ed., Oxford
University Press, 2006, pp. 91–115.
[26] C.O.S. Sorzano, R. Marabini, J. Velazquez-Muriel, J.R. Bilbao-Castro, S.H.W. Scheres,
J.M. Carazo, A. Pascual-Montano, XMIPP: a new generation of an open-source
image processing package for electron microscopy, J. Struct. Biol. 148 (2004)
194–204.
[27] L. Lebeau, F. Lach, C. Vénien-Bryan, A. Renault, J. Dietrich, T. Jahn, M.G. Palmgren,
W. Kühlbrandt, C. Mioskowski, Two-dimensional crystallization of a membrane
protein on a detergent-resistant lipid monolayer, J. Mol. Biol. 308 (4) (2001)
639–647.
2800 D. Teboul et al. / Biochimica et Biophysica Acta 1818 (2012) 2791–2800[28] L. Chièze, V.M. Bolanos-Garcia, M. Pinot, B. Desbat, A. Renault, S. Beauﬁls, V. Vié,
Fluid and condensed ApoA-I/phospholipid monolayers provide insights into
ApoA-I membrane insertion, J. Mol. Biol. 410 (1) (2011) 60–76.
[29] M.T. Paternostre, M. Roux, J.L. Rigaud, Mechanisms of membrane protein insertion
into liposomes during reconstitution procedures involving the use of detergents.
1. Solubilization of large unilamellar liposomes (prepared by reverse-phase evapo-
ration) by triton X-100, octyl glucoside, and sodium cholate, Biochemistry 27 (8)
(1988) 2668–2677.
[30] J.L. Rigaud, M.T. Paternostre, A. Bluzat, Mechanisms of membrane protein inser-
tion into liposomes during reconstitution procedures involving the use of deter-
gents. 2. Incorporation of the light-driven proton pump bacteriorhodopsin,
Biochemistry 27 (8) (1988) 2677–2688.
[31] J.L. Rigaud, D. Lévy, Reconstitution of membrane proteins into liposomes,
Methods Enzymol. 372 (2003) 65–86.
[32] J.-J. Lacapère, D.L. Stokes, A. Olofsson, J.L. Rigaud, Two-dimensional crystallization
of Ca-ATPase by detergent removal, Biophys. J. 75 (3) (1998) 1319–1329.
[33] J.L. Rigaud, G. Mosser, J.-J. Lacapere, A. Olofsson, D. Levy, J.L. Ranck, Bio-beads: an
efﬁcient strategy for two-dimensional crystallization of membrane proteins,
J. Struct. Biol. 118 (3) (1997) 226–235.[34] N. Jamin, J.-J. Lacapere, Cicular dichroism: folding and conformational changes
of membrane proteins, In: in: E. Pebay-Peyroula (Ed.), Biophysical Analysis of
Membrane Proteins, Wiley-VCH Verlag GmbH & Co. KGaA, Weiheim, 2008,
pp. 243–258.
[35] M.R. Dorwart, R. Wray, C.A. Brautigam, Y. Jiang, P. Blount, S. Aureus, MscL is a
pentamer in vivo but of variable stoichiometries in vitro: implications for
detergent-solubilized membrane proteins, PLoS Biol. 8 (12) (2010) e1000555.
[36] M.A. Ostuni, G. Péranzi, R.A. Ducroc, M. Fasseu, B. Vidic, J. Dumont, V.
Papadopoulos, J.-J. Lacapere, Distribution, pharmacological characterization and
function of the 18 kDa translocator protein in rat small intestine, Biol. Cell 101
(10) (2009) 573–586.
[37] A.A. Yeliseev, S. Kaplan, TspO of rhodobacter sphaeroides. A structural and func-
tional model for the mammalian peripheral benzodiazepine receptor, J. Biol.
Chem. 275 (8) (2000) 5657–5667.
[38] N. Boujrad, B. Vidic, V. Papadopoulos, Acute action of choriogonadotropin on Leydig
tumor cells: changes in the topography of themitochondrial peripheral-type benzo-
diazepine receptor, Endocrinology 137 (12) (1996) 5727–5730.
[39] A.M. Scarf, M. Kassiou, The translocator protein, J. Nucl. Med. 52 (5) (2011)
677–680.
